Royalty Pharma plc
RPRX
Kedudukan dalam Saham
#881
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Harga Saham
$61.00
Modal Pasaran
$27.16B
Perubahan (1 hari)
0.06%
Perubahan (1 tahun)
64.81%
Negara
US
Perdagangan Royalty Pharma plc (RPRX)
Kategori
Healthcare
EPS untuk Royalty Pharma plc (RPRX)
EPS setakat June 2026 TTM: $2.41
Menurut laporan kewangan terkini dan harga saham Royalty Pharma plc, EPS semasa syarikat (TTM) adalah $2.41. Pada akhir tahun 2024, syarikat mempunyai EPS sebanyak $1.92 penurunan berbanding EPS tahun 2023 iaitu $2.54.
Sejarah EPS untuk Royalty Pharma plc dari 2015 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $2.41 | 34.64% |
| 2025 | $1.79 | -6.61% |
| 2024 | $1.92 | -24.41% |
| 2023 | $2.54 | 2,492.43% |
| 2022 | $0.10 | -93.45% |
| 2021 | $1.49 | -42.47% |
| 2020 | $2.60 | -59.54% |
| 2019 | $6.42 | 182.80% |
| 2018 | $2.27 | 13.86% |
| 2017 | $1.99 | 113.83% |
| 2016 | $0.93 | -2.67% |
| 2015 | $0.96 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.02 | -99.22% |
HK
|
|
| $0.52 | -78.42% |
US
|
